Structure of anaemic conditions comorbid to alcoholic and non-alcoholic steatohepatitis
DOI:
https://doi.org/10.12775/JEHS.2021.11.05.015Keywords
alcoholic steatohepatitis, non-alcoholic steatohepatitis, anaemia, Н.pyloryAbstract
The retrospective analysis of 378 medical records of inpatients with steatohepatitis (SH) depending on its etiology was performed to identify and study the type of anaemic conditions (AC). Among patients with SH of mixed (including alcoholic) etiology anaemia was found in 32.2% of cases, in patients with alcoholic (ASH) - in 36.3%, in patients with non-alcoholic SH (NASH) - in 22.0 % of cases. Macrocytic, hyperchromic anaemia prevailed in patients with anaemia of all groups: in patients with SH of mixed etiology - in 47.9%, in patients with ASH - 56.8%, NASH - 71.4%. Normocytic, normochromic anaemia was registered in 52.1% with mixed etiology of SH, in patients with ASH - 43.2%, NASH - 28.6%.
The prospective study of 125 patients with SH showed that anaemia was found in 40.0% of patients with ASH, among patients with SH of mixed (including alcoholic) etiology anaemia was found in 32.0%, among patients with NASH the result was 21.7%. The following types of anaemia were found in ASH: vitamin B12 - deficient - in 17.5% of cases, anaemia of chronic disease - in 10.0% of cases and Zieve's syndrome - in 12.5% of cases. Three types of anaemia were found in patients with SH of mixed etiology: vitamin B12 - deficient - in 16.0% of cases, anaemia of chronic disease - in 8.0% and Zieve's syndrome - in 8.0% of patients. The structure of anaemias in patients with NASH accompanied by obesity of I-II degrees is as follows: B12 - deficient anaemia - in 15.0% of cases, anaemia of chronic disease - in 6.7% of people. In patients with NASH, H. pylory contamination was present in 84.6% of patients with anaemic syndrome (AS), including 100% of patients with B12-deficient anaemia. With ASH, H. pylory contamination was present in 80.0% with anaemia, including 100% of patients with B12-deficient anaemia. In patients with SH of mixed etiology, H. pylory contamination was present in 100.0% of people with AS.
References
Bogusch LC. Algoritm diagnoctiki naruschenij obmena zhelesom u bol'nych chronitscheckimi divvusnymi sabolewanijami petscheni. Problemy sdorow'ja i jekologii. 2015;(1):142–148.
Vygovs'ka JaI. Anemija hronichnyh hvorob: patogenez, diagnostyka, likuvannja (lekcija). Ukr. med chasopys. 2012; XI/XII (6 (92)):76-79.
Nakaz MOZ Ukrai'ny vid 2 lystopada 2015 r. № 709 «Unifikovanyj klinichnyj protokol pervynnoi' ta vtorynnoi' (specializovanoi') medychnoi' dopomogy «Zalizodeficytna anemija». https://dec.gov.ua/wp-content/uploads/2019/11/2015_709_ykpmd_zda.pdf
Nakazom MOZ Ukrai'ny vid 30 chervnja 2010 r. № 647 «Pro zatverdzhennja klinichnyh protokoliv nadannja medychnoi' dopomogy hvorym zi special'nosti «Gematologija». https://zakon.rada.gov.ua/rada/show/v0647282-10#Text
Nockowa KK, Mel'kina EC, Drosdow WN. Racproctranennoct' i kliniko-morvologitscheckie charakterictiki anemii u bol'nych chronitscheckimi sabolewanijami petscheni. Jekcperimental'naja i klinitscheckaja gactrojenterologija. 2010; (10):8-11.
Khukhlina OS, Antonov AA, Mandryk OE, Hryniuk OE. Non-alcoholic fatty liver disease and comorbid conditions: features of pathogenesis, clinic, diagnosis, treatment. Chernivtsi, 2017. 188 p.
Bekri S., Gual P., Anty R. et al. Increased adipose tissue expression of hepcidin in severy obesity is independent from diabetes and NASH. Gastroenterology, 2006; 131:788–796.
Bergamaschi G, Di Sabatino A, Corazza GR. Pathogenesis, diagnosis and treatment of anaemia in immune-mediated gastrointestinal disorders. Br J Haematol, 2018; 182:319.
Britton LJ, Subramaniam VN, Crawford DH. Iron and non-alcoholic fatty liver disease. World J Gastroenterol, 2016;22:8112–8122.
Camaschella C. Iron-deficiency anemia. N Engl J Med 2015; 372:1832.
Cappellini MD, Comin-Colet J, de Francisco A, et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. Am J Hematol, 2017; 92:1068.
Docherty AB, Turgeon AF, Walsh TS. Best practice in critical care: anaemia in acute and critical illness. Transfus Med, 2018; 28:181.
Fraenkel PG. Anemia of inflammation: a review. The Medical Clinics of North America, 2017;101(2):285−296.
Gangat N, Wolanskyj AP. Anemia of chronic disease. Semin Hematol, 2013; 50:232.
Ganz T, Nemeth E. Iron homeostasis in host defence and inflammation. Nat Rev Immunol, 2015; 15:500.
Ganz T. Anemia of Inflammation. N Engl J Med, 2019; 381:1148.
Ganz T. Erythropoietic regulators of iron metabolism. Free Radic Biol Med, 2019; 133:69.
Gerjevic LN, Liu N, Lu S, Harrison-Findik DD. Alcohol activates TGF-beta but inhibits BMP receptor-mediated SMAD signaling and SMAD4 binding to hepcidin promoter in the liver. Int J Hepatol, 2012;2012:459278.
Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood, 2016; 127:2809.
Harrison-Findik DD, Schafer D, Klein E, Timchenko NA, Kulaksiz H, Clemens D, et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem, 2006;281:22974–22982.
Hernandez Roman J, Siddiqui MS. The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease. Endocrinol Diabetes Metab, 2020 Apr 5;3(4):e00127. doi: 10.1002/edm2.127.
Hutchinson C. A review of iron studies in overweight and obese children and adolescents: a double burden in the young? Eur J Nutr 2016; 55:2179.
Jelkmann W. Regulation of erythropoietin production. J Physiol, 2011; 589:1251.
Malfertheiner P, Mégraud F, O’Morain C et al. European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection – the Maastricht V/Florence Consensus Report. Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288.
Milic S, Mikolasevic I, Orlic L, Devcic E, Starcevic-Cizmarevic N, Stimac D, et al. The role of iron and iron overload in chronic liver disease. Med Sci Monit, 2016;22:2144–2151.
Nemeth E, Ganz T. Anemia of inflammation. Hematology/Oncology Clinics of North America, 2014;28(4):671–681.
Neuschwander-Tetri BA. Therapeutic landscape for NAFLD in 2020. Gastroenterology, 2020 May;158(7):1984-1998.e3. doi: 10.1053/j.gastro.2020.01.051.
Ntandja Wandji LC, Gnemmi V, Mathurin P, Louvet A. Combined alcoholic and non-alcoholic steatohepatitis. JHEP Rep, 2020 May 22;2(3):100101. doi: 10.1016/j.jhepr.2020.100101.
Qu X-H, Huang X-L, Xiong P, et al. Does Helicobacter pylori infection play a role in iron deficiency anemia? A metaanalysis. World J Gastroenterol. 2010;16:886-96. doi: 10.3748/ wjg.v16.i7.886.
Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Nonalcoholic steatohepatitis: a review. JAMA, 2020 Mar 24;323(12):1175-1183. doi: 10.1001/jama.2020.2298.
Theurl I, Hilgendorf I, Nairz M, et al. On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver. Nat Med, 2016; 22:945.
Torino AB, Gilberti Mde F, da Costa E, et al. Evaluation of erythrocyte and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease. Rev Bras Hematol Hemoter, 2015; 37:77.
van Santen S, de Mast Q, Oosting JD, et al. Hematologic parameters predicting a response to oral iron therapy in chronic inflammation. Haematologica, 2014; 99:e171.
Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood, 2019; 133:40.
Weiss G. Anemia of Chronic Disorders: New Diagnostic Tools and New Treatment Strategies. Semin Hematol, 2015; 52:313.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 471
Number of citations: 0
